CYP3A5 and cardiomyopathy: The CYP3A5-rs4646450-TT and the SLC28A3- rs7853758-AA genotypes were associated respectively with a 6.6-fold (95% CI: 1.7–25.7, p = 7.00 × 10−3) and 9.8-fold (95% CI: 1.7–56.0, p = 0.01) increased risk of cardiomyopathy [31].